France · Question · Question écrite
4941
Question 4941 — pharmacie et médicaments
Introduced
—
Last action
—
Status
posée
Sponsors
—
Subjects
Labour
Source updated
—
Summary
M. Jean-Bernard Sempastous attire l'attention de Mme la ministre des solidarités et de la santé sur la situation des femmes exposées in utero au distilbène qui encourent des risques particuliers tels que la survenue d'adénocarcinomes à cellules claires du col utérin ou du vagin ou des risques accrus de cancer du sein ou de dysplasies. Ces risques nécessitent un dépistage particulier, tous les ans, par un frottis spécifique. Aussi, il souhaiterait connaître les intentions du Gouvernement pour que ces consultations puissent bénéficier d'une prise en charge à 100 %.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
2 official files
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Réponse
text · FR
Question
text · FR
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Sponsors
- Jean-Bernard Sempastous · auteur
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.assemblee-nationale.fr/dyn/15/questions/QANR5L15QE4941
- Open data entity: https://www.assemblee-nationale.fr/dyn/opendata/QANR5L15QE4941
- france · QANR5L15QE4941